Moneycontrol Be a Pro
Get App
you are here: HomeNewsBusiness
Last Updated : Feb 12, 2019 11:37 AM IST | Source: PTI

Dr Reddy's launches erectile dysfunction treatment drug in US

Quoting IMS Health data, Dr Reddy's Laboratories said, the Adcirca brand and generic had US sales of approximately USD 490 million for the most recent twelve months ending in November 2018.

Representative Image
Representative Image
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Dr Reddy's Laboratories on Tuesday said it has launched Tadalafil tablets, used to treat erectile dysfunction, in the US market. Tadalafil tablets are a therapeutic equivalent generic version of Adcirca tablets, Dr Reddy's Laboratories said in a BSE filing.

Quoting IMS Health data, Dr Reddy's Laboratories said, the Adcirca brand and generic had US sales of approximately USD 490 million for the most recent twelve months ending in November 2018.

Shares of Dr Reddy's were trading 0.01 per cent lower at Rs 2,616.70 apiece on the BSE.

The Great Diwali Discount!
Unlock 75% more savings this festive season. Get Moneycontrol Pro for a year for Rs 289 only.
Coupon code: DIWALI. Offer valid till 10th November, 2019 .
First Published on Feb 12, 2019 11:31 am
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant